Study: COVID Vaccine Won’t Trigger MS Relapse
Newsmax Health Multiple sclerosis makes people vulnerable to more severe cases of COVID-19, but a new study finds that getting the COVID vaccine won't trigger a relapse of MS symptoms.…[...]
Read More
Newsmax Health Multiple sclerosis makes people vulnerable to more severe cases of COVID-19, but a new study finds that getting the COVID vaccine won't trigger a relapse of MS symptoms.…[...]
Read More
Alex Zxi Jian Ho • Nur Izzati B. Ishak • Eugene Hung Chih Wong, Published: June 06, 2024, DOI: 10.7759/cureus.61855 Cite this article as: Ho A, Ishak N B, Wong E (June 06, 2024) Effect of Olfactory Rehabilitation…[...]
Read More
MAR 01, 2024 - Authored by Marina Zhang via The Epoch Times Dr. Clarice Saba, an otorhinolaryngologist in Brazil, developed sudden hearing loss in her right ear a week after…[...]
Read More
by Jason Gale Feb 20, 2024 Microsoft Start (Bloomberg) -- Vaccines that protect against severe illness, death and lingering long Covid symptoms from a coronavirus infection were linked to small increases in…[...]
Read More
By Jim Hᴏft Nov. 28, 2023 The Gateway Pundit Since the introduction of the experimental COVID-19 vaccines, The Gateway Pundit has been covering numerous studies from health professionals, revealing startling findings that mRNA…[...]
Read More
A study has found that people who got COVID-19 shots in the same arm had a more effective vaccine than people who did both. By JUDY SIEGEL-ITZKOVICH: AUGUST 18, 2023…[...]
Read More
Authored by Megan Redshaw via The Epoch Times, FRIDAY, SEP 01, 2023 The U.S. government and pharmaceutical companies are investing a substantial amount to develop new mRNA vaccines for infectious…[...]
Read More
Authors: Jack Phillips via The Epoch Times, May 7, 2022 The U.S. Centers for Disease Control and Prevention (CDC) is investigating more than 100 cases of a mysterious form of hepatitis in…[...]
Read More
Authors: RHODA WILSON AUGUST 30, 2021 It is a human right, and global law governed under the Nuremberg Code, that vaccine specific ingredient information is disclosed. It is critical, required…[...]
Read More
Authors: The Lancet We are writing to express concern about the use of a recombinant adenovirus type-5 (Ad5) vector for a COVID-19 phase 1 vaccine study,1 and subsequent advanced trials. Over…[...]
Read More